Geneos Wealth Management’s American Express AXP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.09M Sell
3,208
-41
-1% -$13.1K 0.02% 529
2026
Q1
$983K Buy
3,249
+82
+3% +$27.5K 0.02% 515
2025
Q4
$1.17M Buy
3,167
+30
+1% +$10.7K 0.03% 462
2025
Q3
$1.04M Sell
3,137
-662
-17% -$211K 0.03% 477
2025
Q2
$1.21M Sell
3,799
-18,224
-83% -$5.13M 0.03% 487
2025
Q1
$5.93M Buy
22,023
+15,821
+255% +$4.68M 0.09% 276
2024
Q4
$1.84M Buy
6,202
+313
+5% +$89.9K 0.06% 302
2024
Q3
$1.6M Buy
5,889
+406
+7% +$101K 0.06% 318
2024
Q2
$1.27M Buy
5,483
+3,262
+147% +$755K 0.06% 319
2024
Q1
$506K Buy
2,221
+102
+5% +$21.1K 0.02% 486
2023
Q4
$397K Sell
2,119
-569
-21% -$91.6K 0.02% 531
2023
Q3
$401K Buy
2,688
+396
+17% +$64.8K 0.02% 508
2023
Q2
$399K Sell
2,292
-2,354
-51% -$380K 0.02% 503
2023
Q1
$766K Sell
4,646
-939
-17% -$156K 0.05% 351
2022
Q4
$825K Buy
5,585
+730
+15% +$108K 0.05% 307
2022
Q3
$655K Sell
4,855
-8,652
-64% -$1.31M 0.05% 332
2022
Q2
$1.9M Buy
13,507
+5,884
+77% +$972K 0.09% 218
2022
Q1
$1.43M Buy
7,623
+203
+3% +$36.7K 0.06% 274
2021
Q4
$1.21M Sell
7,420
-609
-8% -$104K 0.05% 348
2021
Q3
$1.4M Buy
8,029
+36
+0.5% +$6.02K 0.05% 309
2021
Q2
$1.35M Sell
7,993
-438
-5% -$68.6K 0.05% 298
2021
Q1
$1.29M Sell
8,431
-52
-0.6% -$6.87K 0.04% 359
2020
Q4
$1.12M Sell
8,483
-14,206
-63% -$1.57M 0.05% 319
2020
Q3
$2.19M Buy
22,689
+1,451
+7% +$143K 0.11% 187
2020
Q2
$1.98M Buy
21,238
+2,108
+11% +$194K 0.11% 192
2020
Q1
$1.7M Sell
19,130
-1,900
-9% -$221K 0.11% 184
2019
Q4
$2.63M Buy
21,030
+2,603
+14% +$311K 0.14% 172
2019
Q3
$2.19M Buy
18,427
+3,194
+21% +$392K 0.13% 172
2019
Q2
$1.89M Buy
15,233
+2,509
+20% +$295K 0.12% 182
2019
Q1
$1.39M Buy
12,724
+3,199
+34% +$336K 0.09% 219
2018
Q4
$909K Buy
9,525
+2,097
+28% +$219K 0.07% 264
2018
Q3
$791K Buy
7,428
+322
+5% +$33.5K 0.05% 304
2018
Q2
$696K Sell
7,106
-173
-2% -$17K 0.05% 275
2018
Q1
$679K Buy
7,279
+75
+1% +$7.26K 0.06% 260
2017
Q4
$715K Buy
7,204
+350
+5% +$33.3K 0.06% 264
2017
Q3
$620K Buy
6,854
+121
+2% +$10.4K 0.06% 266
2017
Q2
$567K Sell
6,733
-58
-0.9% -$4.59K 0.06% 268
2017
Q1
$537K Buy
6,791
+478
+8% +$37.4K 0.06% 259
2016
Q4
$467K Sell
6,313
-249
-4% -$17.2K 0.06% 260
2016
Q3
$420K Buy
6,562
+1,109
+20% +$71.2K 0.06% 280
2016
Q2
$330K Buy
5,453
+52
+1% +$3.29K 0.05% 321
2016
Q1
$330K Buy
+5,401
New +$314K 0.05% 316

Other funds holding AXP

Geneos Wealth Management's AXP Position: Q2 2026 in Review

Geneos Wealth Management reduced its American Express (AXP) stake by 1.3% in Q2 2026, selling an estimated $13.1K and leaving 3,208 shares worth $1.09M. The position accounts for 0.02% of the portfolio, ranked #529.

Geneos Wealth Management first reported a position in AXP in Q1 2016 and has held it in 42 quarters since. The position peaked at $5.93M in Q1 2025. 2,992 funds tracked by Wall St. Rank hold AXP as of Q2 2026.

  • Geneos Wealth Management held 3,208 shares of American Express worth $1.09M as of Q2 2026.
  • Geneos Wealth Management sold 41 American Express shares in Q2 2026, an estimated $13.1K.
  • American Express made up 0.02% of Geneos Wealth Management's portfolio in Q2 2026, its #529 holding.
  • Geneos Wealth Management first reported a position in American Express in Q1 2016 and has held it in 42 quarters since.
  • Geneos Wealth Management's American Express position peaked at $5.93M in Q1 2025.
  • 2,992 funds tracked by Wall St. Rank held American Express as of Q2 2026.

Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.